openPR Logo
Press release

Global Peptides and Heparin Market Research by Region - North America, Latin America, Europe, Japan, APEJ, MEA; Product Type - Sodium Heparin, Ammonium Heparin, lithium Heparin, Icatibant, Bivalirudin, Liraglutide, Exenatide, Goserelin, Bortezomib, Other

07-27-2018 12:57 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

/ PR Agency: media@factmr.com
Fact.MR

Fact.MR

A fresh study, covering “Peptide and Heparin Market Research Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2026” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make the research a powerful source for analysts and industry experts who are looking to gain necessary knowledge about the prevailing market trends, opportunities and drivers present in the peptide and heparin market. 

Request Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=378

Drug Developers Shifting Back to Peptides owing to Mounting Challenges regarding Small Molecules

While the pharmaceutical sector discerned small molecules as the medicinal agents, therapeutic peptides were considered to be niche products. However, with mounting challenges regarding small molecules, drug developers are shifting their concentration back to small amino acid chains. Although peptides have been deemed ineffective for developing drugs, modern peptide drug designs and formulations have been developed for circumventing their weaknesses. For example, original requirement for injecting peptides such as insulin is fading, with more patient-friendly administrations progressively being developed. In addition, the current society that critically judges undesirable effects and environmental impact of the candidate medicines is embracing the safety offered by peptides.

Heparin is being extensively employed as an antitumor and anti-inflammatory agent. The anti-inflammatory characteristic of heparin, which prevents metastatic spreading of tumor cells, is a new research finding among healthcare professionals. The metastatic spreading of tumor cells is restricted by heparin through neutralization of cationic mediators, inhibition of heparanase, and adhesion molecules. Recent discoveries have meant that heparin is capable of targeting L- and P-selectin & integrin activity, as well as preventing cancer progression.

Liraglutide and ammonium heparin are expected to remain fast-expanding products in the market. In addition, sales of exenatide, lithium heparin, and sodium heparin will register a similar CAGR through 2026.

Key Research Findings from Fact.MR’s Report on Peptide and Heparin Market

1- Oral route of administration will remain preferred for peptide and heparin

2- Cancer will continue to be the dominant indication segment in the market, in terms of revenues

3- Hospital pharmacies will remain the most lucrative distribution channel for peptide and heparin

Competition Tracking

The global market for peptide and heparin is high fragmented and competitive owing to the presence of a large number of international and regional vendors. These vendors are continuously focusing on the development of generic formulations related to blood coagulation and several other novel therapeutic areas. Companies having the capability of manufacturing drugs for effective treatment of coagulation disorders, along with high efficacy and safety profiles are likely to gain maximum market shares in the foreseeable future. Key market participants identified by the report include Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm, Inc., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., Bachem, Abbott Laboratories, Pfizer Inc., Aspen, Leo Pharma, Teva, Takeda, Sanofi, Novo Nordisk, and Eli Lilly.

View Full Report with TOC@ https://www.factmr.com/report/378/peptides-heparin-market

Table of Contents:

Global Economic Outlook
Global Peptide and Heparin Market - Executive Summary
Global Peptide and Heparin Market Overview
3.1. Introduction
     3.1.1. Global Peptide and Heparin Market Taxonomy
     3.1.2. Global Peptide and Heparin Market Definition
3.2. Global Peptide and Heparin Market Size (US$ Mn) and Forecast, 2012-2026
       3.2.1. Global Peptide and Heparin Market Y-o-Y Growth
3.3. Global Peptide and Heparin Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. PESTLE Analysis
3.7. Product Lifecycle
3.8. List of Distributors
3.9. Key Participants Market Presence (Intensity Map) By Region
Global Peptide and Heparin Market Analysis and Forecast 2012-2026 
4.1. Global Peptide and Heparin Market Size and Forecast By Product Type , 2012-2026
     4.1.1. Sodium Heparin Market Size and Forecast, 2012-2026
              4.1.1.1. Revenue (US$ Mn) Comparison, By Region
                4.1.1.2. Market Share Comparison, By Region
                4.1.1.3. Y-o-Y growth Comparison, By Region
Continued………

Buy this Report@ https://www.factmr.com/checkout/378/S

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow Us on Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Peptides and Heparin Market Research by Region - North America, Latin America, Europe, Japan, APEJ, MEA; Product Type - Sodium Heparin, Ammonium Heparin, lithium Heparin, Icatibant, Bivalirudin, Liraglutide, Exenatide, Goserelin, Bortezomib, Other here

News-ID: 1149975 • Views: 150

More Releases from Fact.MR

Ergonomic Designs of Furniture and a Favourable Policy Framework for Newer Entra …
The global office furniture market is expected to create ~ US$ 22 Billion worth of incremental opportunity over the forecast period. Since the last two decades, the number of small, micro, and medium-sized enterprises has increased drastically in developed and developing countries. Moreover, constant provision from private investments and governments is fueling the growth of the private sector, which is further propelling the office furniture market growth to a great
Cyclopentane Market Statistics Based on Upcoming Chemical Industry Trends and Su …
The adoption of cyclopentane in commercial refrigerators has opened up new opportunities for the global cyclopentane market. Cyclopentane is popularly used as a foam blowing agent for polyurethane foams that are used to insulate freezers and refrigerators. The commercial refrigerator sector is experiencing a healthy growth across the globe, with Asia pacific region as the fastest growing region. The importance of commercial refrigerators is also increasing due to fluctuating climatic
Advanced Technologies in Blow Molded Containers Market Will Offer Lucrative Grow …
The global food & beverage industry accounts for the lion’s share in the blow molded containers market. The industry has shown fast pace growth in the recent years owing to rise in population and increase in per capita consumer spending, thereby driving expansion in the blow molded containers market. Concerning revenue, the global blow molded containers market is projected to expand at a CAGR of ~ 6% during the forecast
Squeezable Plastic Tubes Show Maximum Penetration in the Beauty and Personal Car …
Global sales of the squeezable plastic tubes in 2018 surpassed US$ 700 Mn and are anticipated to expand at a moderate pace over the forecast period, according to a recently published Fact.MR study. Europe will maintain its supremacy in the market for the squeezable plastic tubes, owing to the widespread consumption in various end-use applications of squeezable plastic tubes. Emerging markets like India, China, North Middle East & Africa, etc.

All 5 Releases


More Releases for Heparin

Global Heparin(Heparin Sodium and Heparin Calcium) Market drivers, restraints, g …
Latest industry research report on: Global Heparin(Heparin Sodium and Heparin Calcium) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the global Heparin(Heparin Sodium and Heparin Calcium) market status and forecast, categorizes the global Heparin(Heparin Sodium and Heparin Calcium) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China,
Global Heparin(Heparin Sodium and Heparin Calcium) Market Professional Survey Re …
"The Report Global Heparin(Heparin Sodium and Heparin Calcium) Market Professional Survey Report 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" This report studies Heparin(Heparin Sodium and Heparin Calcium) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report
10-11-2017 | Health & Medicine
TMR
Heparin Market – Global Industry Analysis 2016
The heparin market in Europe is rather consolidated, with the Sanofi, Aspen, Pfizer, and Leo Pharma accounting for over 65% of the market in 2015. In a new study, Transparency Market Research (TMR) has found that Sanofi is the clear leader in the Europe heparin market, enjoying a 47.5% share in 2015. Increased global sales of Lovenox can be attributed to the company’s success.   “A focus on the expansion of R&D activities, in-licensing
Heparin Market: Professional and Technical Industry Insights
Global Heparin Market: Key Trends  The prevalence of coagulation disorders such as venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE) has remarkably increased in both Europe and North America. Since heparin is one of the foremost clinical anticoagulants, the rising incidence of coagulation disorders will in turn fuel demand for heparin products, finds Transparency Market Research (TMR). Currently, heparin manufacturers are focusing on the development of generic versions
07-18-2017 | Health & Medicine
Heparin
2014 - 2022: Qualitative And Quantitative Analysis Of Heparin Market In Europe B …
Researchmoz added Most up-to-date research on "2014 - 2022: Qualitative And Quantitative Analysis Of Heparin Market In Europe By Product Such As Unfractionated Heparin, Low Molecular Weight Heparin & Ultra Low Molecular Weight Heparin" to its huge collection of research reports. This report provides in-depth analysis of the heparin market in Europe. Stakeholders for this report include manufacturers of heparin products, crude heparin suppliers, heparin processing companies, and new players planning
Europe Heparin Sodium Market Research Report 2017
Report Hive market Research Released a New Research Report of 144 pages on Title "Europe Heparin Sodium Market Research Report 2017"with detailed Analysis, Forecast and Strategies. The Europe Heparin Sodium Market Research Report 2017 is a professional and in-depth study on the current state of the heparin sodium market. Annual estimates and forecasts are provided for the period 2017 through 2023. Also, a six-year historic analysis is provided for these markets.